November 30, 2023
- November 30, 2023 - Notice of Change: Extension of PAR-22-030 "Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)" by one Council Round. See Notice NOT-NS-24-020.
- November 9, 2021 - Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed). See NOFO PAR-22-028.
National Institute of Neurological Disorders and Stroke (NINDS)
The purpose of this notice is to inform applicants of an extension to PAR-22-028 "Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed)". The NOFO will be extended by one additional council round. Due to the extension, the following dates have been added: New and Resubmission due date: October 1, 2024-January 24, 2025. Expiration date January 25, 2025. Changes to the NOFO are shown below.
Currently Reads:
Part 1. Overview Information
Key Dates
Application Due Date(s)
December 22, 2021 - January 31, 2022
February 1, 2022 - May 31, 2022
June 1, 2022 - September 30, 2022
October 1, 2022 - January 31, 2023
February 1, 2023 - May 31, 2023
June 1, 2023 - September 30, 2023
October 1, 2023 - January 31, 2024
February 1, 2024- May 31, 2024
June 1, 2024 - September 31, 2024
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Application Due Date(s)
Not Applicable
Scientific Merit Review
March 2022, July 2022, November 2022, March 2023, July 2023, November 2023, March 2024, July 2024, November 2024
Advisory Council Review
May 2022; October 2022; January 2023; May 2023; October 2023; January 2024; May 2024; October 2024; January 2025
Earliest Start Date
June 2022, November 2022, February 2023, June 2023, November 2023, February 2024, June 2024, November 2024, February 2025
Expiration Date: October 1, 2024
Modified to Read:
Part 1. Overview Information
Key Dates
Application Due Date(s)
December 22, 2021 - January 31, 2022
February 1, 2022 - May 31, 2022
June 1, 2022 - September 30, 2022
October 1, 2022 - January 31, 2023
February 1, 2023 - May 31, 2023
June 1, 2023 - September 30, 2023
October 1, 2023 - January 31, 2024
February 1, 2024- May 31, 2024
June 1, 2024 - September 30, 2024
October 1, 2024-January 24, 2025
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Application Due Date(s)
Not Applicable
Scientific Merit Review
March 2022, July 2022, November 2022, March 2023, July 2023, November 2023, March 2024, July 2024, November 2024, March 2025
Advisory Council Review
May 2022; October 2022; January 2023; May 2023; October 2023; January 2024; May 2024; October 2024; January 2025, May 2025
Earliest Start Date
June 2022, November 2022, February 2023, June 2023, November 2023, February 2024, June 2024, November 2024, February 2025, June 2025
Expiration Date: January 25, 2025
All other aspects of this NOFO remain unchanged.
Chris Boshoff, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-1779
Email: chris.boshoff@nih.gov
and Human Services (HHS)
